2015 Next Generation Dx Summit

Short Courses

MONDAY, AUGUST 17

9:00 am - 12:00 pm

SC1: Use of FFPE/Fixed Tissues for Clinical Research - Detailed Agenda  

P. Mickey Williams, Ph.D., Director, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research

Jason Lih, Ph.D., Principal Scientist, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research

Biswajit Das, Ph.D., Senior Scientist, MoCha, Frederick National Laboratory for Cancer Research Leidos Biomedical Research, Inc., National Cancer Institute (NCI)

Christopher R. Kinsinger, Ph.D., Program Manager, Office of Cancer Clinical Proteomics Research, NCI

Ping Guan, Ph.D., Program Director, Biorepositories and Biospecimen Research Branch (BBRB), National Cancer Institute (NCI)
Wendell Jones, Ph.D., Global Head Genomic Bioinformatics, EA Quintiles
 

SC2: Method Validation According to CLSI Guidelines - Detailed Agenda 

Shuguang Huang, Ph.D., Associate Vice President, Biostatistics, Helomics

SC3: Practical Considerations for NGS Data Analysis and Interpretation - Detailed Agenda 

Robert D. Daber, Ph.D., Director, Research and Development and Sequencing Operations,
Bio-Reference Laboratories

Matthew Lebo, Ph.D., FACMG, Director, Bioinformatics, Partners Personalized Medicine; Instructor, Pathology, Brigham and Women’s and Massachusetts General Hospitals

2:00 - 5:00 pm

SC5: Microfluidics for Point-of-Care - Detailed Agenda 

Holger Becker, Ph.D., Founder & CSO, microfluidic ChipShop GmbH

SC6: Establishing the Value of Diagnostic Tests - Detailed Agenda 

Lawrence J. Worden, Vice President and Senior Partner, Market Diagnostics International

Rahul K. Dhanda,Vice President, Marketing, T2 Biosystems, Inc. 

Mark S. Girardi, Principal Consultant, GfK Market Access 

 

SC7: NGS as a Diagnostics Platform - Detailed Agenda 

Jamie Platt, Ph.D., Vice President, Genomic Solutions, Molecular Pathology Laboratory Network, Inc.

Jennifer Morrissette, Ph.D., Scientific Director, Clinical Cytogenetics Laboratory, Clinical Director, Center for Personalized Diagnostics (CPD), University of Pennsylvania School of Medicine

Justin Zook, Ph.D., Biomedical Engineer, National Institute of Standards and Technology

SC8: Detection and Characterization of Circulating Biomarkers - Detailed Agenda 

Nishant Agrawal, M.D., Associate Professor, Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine

Chetan Bettegowda, M.D., Ph.D., Assistant Professor, Neurosurgery and Oncology, Johns Hopkins University School of Medicine

Sonya Parpart-Li, Ph.D., Associate Scientist, Personal Genome Diagnostics

 

5:30 - 8:30 pm Dinner Short Course:

SC9: Regulatory Compliance in Molecular Diagnostics - Detailed Agenda  

Melina Cimler, Ph.D., Senior Vice President, Quality & Regulatory, Adaptive Biotechnologies

William Pignato, Founder and Principal, W.J. Pignato & Associates, LLC

Pamela Swatkowski, Director, Global Regulatory Affairs, Abbott Molecular


WEDNESDAY, AUGUST 19

Dinner Short Courses 6:30 - 8:30 pm

SC10: Use of CLIA-Waived POC and Rapid Diagnostic Tests in Community Pharmacies - Detailed Agenda 

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

Donald G. Klepser, Ph.D., MBA, Assistant Professor, Pharmacy Practice, University of Nebraska Medical Center College of Pharmacy

Allison Dering-Anderson, Pharm.D., RP, Clinical Assistant Professor, Pharmacy Practice, University of Nebraska Medical Center College of Pharmacy

SC11: NGS for Infectious Disease Diagnostics - Detailed Agenda 

Charles Chiu, M.D., Ph.D., Associate Professor, Lab Medicine and Infectious Diseases; Director, UCSF-Abbott Viral Diagnostics and Discovery Center; Associate Director, UCSF Clinical Microbiology Laboratory

SC12: Regulatory and Reimbursement Considerations with NGS and Other Multiplex Assays - Detailed Agenda 

Živana Težak, Ph.D., Associate Director, Science and Technology, Personalized Medicine, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health (CDRH), FDA

Girish Putcha, M.D., Ph.D., Director, Laboratory Science, Palmetto GBA (MolDX)

 

*Separate registration required